As President & CEO, Fox Chase Cancer Center, Robert Uzzo is responsible for leading the overall clinical operations of Fox Chase.

In addition to these roles, Uzzo is the G. Willing “Wing” Pepper Chair in Cancer Research and also serves as the organization’s President of the Medical Group. He also serves as the founding Executive Director of the nation’s second largest urologic quality collaborative, the Pennsylvania Urologic Regional Collaborative.

Uzzo’s primary research has been in renal cell carcinoma, with a special focus on clinical decision making, surgical management, and adjuvant therapies. He has been a principal investigator, investigator, or co-principal investigator on dozens of leading national and international trials in urinary cancers that have had a major impact on the field of urology. In addition, he is the developer of the NEPHROMETRY scoring system, which is used to delineate the complexity of renal tumors and impact of care.